Divi's Laboratories Ltd. (DIVISLAB): Divi's Laboratories Share Price rises 2.01% as stock trades at Rs 9,282.50

Divi's Laboratories Share Price is trading at Rs 9,282.50, up 2.01% today, with market capitalisation at Rs 2,41,576.41 crore. The move places Divi's Laboratories Ltd. among the notable stocks in news on a steady market update. The latest Univest data confirms the price rise, but it does not establish a company-specific catalyst. For investors tracking Divi's Laboratories Share Price Today, the key context is simple: the stock opened at Rs 9,109.80, touched Rs 9,301.50, and is trading above the previous close of Rs 9,100. Univest readers can use this move to frame the stock analysis around valuation, sector positioning and company financials rather than relying on an unverified trigger.

For anyone searching Divi's Laboratories Stock News, the current setup shows a large-cap healthcare name with a premium valuation profile. In the first part of the session, the share price rise has been orderly rather than dramatic, and that makes the fundamentals and sector comparison especially relevant. Univest will continue to track Divi's Laboratories Share Price Live, the latest stock news and broader market context as the trade develops.

Divi's Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 9,282.5
Previous Close	Rs 9,100
Today's Move	Rs 182.5 (+2.01%)
Open	Rs 9,109.8
High	Rs 9,301.5
Low	Rs 9,109.8
Turnover	Rs 16.65 crore
Market Capitalisation	Rs 2,41,576.41 crore
Market Cap Category	Large Cap

Divi's Laboratories Ltd. (DIVISLAB) rose to Rs 9,282.5 from the previous close of Rs 9,100, a move of Rs 182.5 or 2.01%. The stock opened at Rs 9,109.8, reached a high of Rs 9,301.5, recorded a low of Rs 9,109.8.

Divi's Laboratories Share Price Today reflects a Rs 182.50 gain from the previous close of Rs 9,100. The stock is trading at Rs 9,282.50, after opening at Rs 9,109.80 and touching a high of Rs 9,301.50. The low for the move so far is Rs 9,109.80, which means the trading range has stayed relatively tight around the opening level even as the share price rise held through the morning. Turnover stands at Rs 16.65 crore. For readers following Divi's Laboratories Share Price Update, the price action shows steady demand rather than a disorderly jump. That is why Divi's Laboratories Stock Performance is drawing attention in stock market today coverage and in broader share market today scans.

Divi's Laboratories Ltd. (DIVISLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 2,41,576.41 crore
P/E Ratio	82.59x
P/B Ratio	13.68x
ROE	16.19%
ROCE	21.51%
EPS	Rs 110.18
Book Value Per Share	Rs 665.36
Dividend Yield	0.33%

Divi's Laboratories Ltd. (DIVISLAB) fundamental metrics show P/E 82.59x, P/B 13.68x, ROE 16.19%, ROCE 21.51%. These figures provide context only and are not a buy or sell signal.

Divi's Laboratories Ltd. has a market capitalisation of Rs 241576.41 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 82.59x, P/B at 13.68x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 16.19% and ROCE of 21.51%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 110.18, book value per share of Rs 665.36, dividend yield of 0.33%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.83x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	82.59x
Benchmark Median P/E	32.83x
Benchmark Average P/E	48.79x
Benchmark P/E Range	3.2x to 659.73x
Company P/B Ratio	13.68x
Benchmark Median P/B	2.92x
Company ROE	16.19%
Benchmark Median ROE	11.78%
Company ROCE	21.51%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 2,41,576.41 crore
Benchmark Median Market Cap	Rs 674.09 crore

Divi's Laboratories Ltd. (DIVISLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 82.59x, which is above the benchmark median of 32.83x, a difference of +151.57%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Divi's Laboratories Ltd. (DIVISLAB) has a ROE of 16.19%, which is above the benchmark median of 11.78%, a difference of +37.44%. Divi's Laboratories Ltd. (DIVISLAB) has a ROCE of 21.51%, which is above the benchmark median of 13.65%, a difference of +57.58%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,55,633.71	37.67	5.27	14.85	19.11
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,84,478.41	84.58	20.55	26.76	19.27
Cipla Ltd.	CIPLA	1,11,888.39	33.19	3.18	11.83	16
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,11,820.18	24.78	4.15	19.69	21.39
Laurus Labs Ltd.	LAURUSLABS	99,417.45	90.93	17.63	18.31	18.2

Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 82.59x compared with the displayed peer median of 37.67x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 16.19% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 21.51% versus the displayed peer median of 19.11%, providing a capital-efficiency comparison. Divi's Laboratories Ltd. (DIVISLAB) has a market capitalisation of Rs 2,41,576.41 crore. Among the 5 peers shown, 1 have a larger market capitalisation.

Why Investors Are Watching Divi's Laboratories

• Divi's Laboratories Share Price is up 2.01% today, keeping the stock in focus in Stocks Rising Today coverage.
• The price is trading at Rs 9,282.50 versus a previous close of Rs 9,100, which makes the share price rise easy to track on Univest.
• Market capitalisation of Rs 2,41,576.41 crore places the company in a large-cap bracket within healthcare.
• P/E of 82.59 and P/B of 13.68 keep valuation central to Divi's Laboratories Fundamental Analysis.
• ROE of 16.19% and ROCE of 21.51% give investors a return-on-capital context that is stronger than the industry median.

About Divi's Laboratories

Divi's Laboratories Ltd. operates in the pharmaceuticals & drugs industry within the healthcare sector. The company is known for its role in pharmaceutical manufacturing and related business activities, and its scale is reflected in a market capitalisation of Rs 2,41,576.41 crore. For investors following Divi's Laboratories Share Price, the business profile matters because the stock is not moving as a small-cap story; it is a large listed healthcare name with established sector visibility. The latest Univest figures show EPS of Rs 110.18, book value of Rs 665.36 and dividend yield of 0.33%, which together offer a compact view of financial quality and shareholder return context. In stock market today terms, Divi's Laboratories Stock News remains relevant because the company combines scale, a premium valuation and return ratios that are competitive inside the broader pharmaceuticals & drugs universe.

Frequently Asked Questions

Why is Divi's Laboratories Share Price rising today?

Ans. Divi's Laboratories Share Price is rising 2.01% to Rs 9,282.50, but the latest Univest figures do not establish a company-specific catalyst. The move is visible in price action, market cap and turnover.

What is Divi's Laboratories Share Price today?

Ans. Divi's Laboratories Share Price Today is Rs 9,282.50, up Rs 182.50 from the previous close of Rs 9,100. The stock touched Rs 9,301.50 and traded from an opening level of Rs 9,109.80.

What is the market capitalisation of Divi's Laboratories?

Ans. Divi's Laboratories has a market capitalisation of Rs 2,41,576.41 crore. That places Divi's Laboratories Share Price in a large-cap healthcare bracket and makes valuation comparisons important for stock analysis.

How does Divi's Laboratories compare with its industry peers?

Ans. Divi's Laboratories Share Price trades at a P/E of 82.59 and P/B of 13.68, above most peers in the supplied set. Its ROE and ROCE are also competitive, especially versus several large listed pharma names.

What do the ROE and ROCE numbers show for Divi's Laboratories?

Ans. ROE is 16.19% and ROCE is 21.51% for Divi's Laboratories. These numbers indicate efficient capital use, and ROCE is stronger than ROE, which supports the fundamental context behind Divi's Laboratories Share Price.

What do EPS and book value mean for Divi's Laboratories?

Ans. EPS stands at Rs 110.18 and book value per share is Rs 665.36. EPS shows earnings attributable to each share, while book value reflects accounting net worth per share for Divi's Laboratories Share Price.

Is Divi's Laboratories expensive compared with the sector?

Ans. Divi's Laboratories Share Price looks premium versus the same-industry median because its P/E of 82.59 exceeds 32.83 and its P/B of 13.68 exceeds 2.92. That pricing is supported by stronger return ratios.

What should investors monitor in Divi's Laboratories Stock News?

Ans. Investors should monitor Divi's Laboratories Share Price, the current valuation gap versus peers, and how the stock trades relative to Rs 9,100 and Rs 9,301.50. Those numbers frame the day’s stock news clearly.

Track Divi's Laboratories Share Price on Univest

Use Divi's Laboratories Ltd. (DIVISLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Univest lets investors track Divi's Laboratories Share Price, Divi's Laboratories Share Price Today, Divi's Laboratories Share Price Live and Divi's Laboratories Share Price Update in one place. Readers can also follow market cap, valuation ratios, company financials, sector context and market insights as the stock moves through the trading day. For stock news and share price rise tracking, Univest keeps the data view simple and practical.